Loading the section
Prices delayed by 15 minutes
Next earnings report: none scheduled in the next five weeks · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Solventum Corporation trades on NYSE under the ticker SOLV. The company belongs to the Health care sector. The trading history on this page starts on 26 March 2024.
Over the past 52 weeks SOLV has traded between 62.38 $ and 94.16 $. As of 09 October 2026 the price stood 75.61 % of the way from the 52-week low to the high.
Over one year SOLV shares rose 19.75 %; over six months they rose 30.57 %. Volatility over 90 days is 30.76 %. Dividends are not included: this is price change only, as of 09 October 2026.
SOLV trades at a price-to-earnings ratio of 10.5, below the sector median of 24.8. Price to sales is 1.8, below the sector median of 3.9. Price to book is 3.0, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 08 October 2026 | 85.80 | 86.79 | 85.25 | 86.41 | 1M |
| 07 October 2026 | 85.62 | 87.25 | 85.30 | 85.88 | 981,100 |
| 06 October 2026 | 88.45 | 88.93 | 86.90 | 87.04 | 914,200 |
| 05 October 2026 | 87.52 | 88.40 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Solventum is the healthcare business spun out of an industrial group: wound care, dentistry, sterilisation.
The portfolio consists of products a hospital buys regularly and in quantity: dressings, sterilisation indicators, dental compounds. Each costs little but is written into a standard procedure, and is therefore purchased continuously and changed rarely.
Separating from the parent brought independence and simultaneously the obligation to build its own functions from scratch — from procurement to information systems — which costs money and distracts. Noticeable debt came with the business. Risks: hospital budgets, integration costs and competition in settled categories. Growth is expected less from new categories than from raising margins the parent had let drift. A dividend is paid.
Address:C/O 3M COMPANY 3M CENTER, BUILDING 275-6W-02, ST. PAUL, MN, 55144-1000, US
Solventum Corporation reported revenue of 8.3B $ and net income of 1.4B $ over the last four quarters. Net margin is 17.33 %. Revenue changed by −0.55 % year over year. Earnings per share are 8.17 $. Market capitalisation is 15.0B $.
SOLV has a return on equity of 28.82 %, above the sector median of −41.68 %. Return on assets is 10.16 %, above the sector median of −32.11 %. Operating margin is 25.54 %, above the sector median of −26.84 %.
| 325M |
| DXCMDexCom, Inc. | 84.15 | −0.31 % | 324M |
| MDLNMedline Inc. | 36.26 | +1.45 % | 297M |
| RMDResMed Inc. | 230.43 | +1.63 % | 276M |
| PODDInsulet Corporation | 135.28 | +0.60 % | 244M |
| 86.74 |
| 88.03 |
| 1M |
| 02 October 2026 | 88.21 | 89.03 | 87.79 | 87.85 | 880,400 |
| 01 October 2026 | 87.82 | 88.55 | 86.26 | 87.77 | 784,500 |
| 30 September 2026 | 89.40 | 89.42 | 88.13 | 88.15 | 689,700 |
| 29 September 2026 | 89.17 | 89.89 | 88.29 | 89.32 | 848,800 |
| 28 September 2026 | 89.01 | 89.89 | 88.36 | 89.54 | 649,100 |
| 25 September 2026 | 88.53 | 89.68 | 88.16 | 89.50 | 578,900 |
| 24 September 2026 | 88.54 | 89.04 | 88.12 | 88.59 | 635,800 |
| 23 September 2026 | 88.18 | 89.52 | 87.74 | 88.37 | 860,100 |
| 22 September 2026 | 89.17 | 89.41 | 88.48 | 88.75 | 651,200 |
| 21 September 2026 | 88.87 | 89.62 | 88.40 | 88.84 | 660,300 |
| 18 September 2026 | 87.61 | 89.53 | 86.53 | 88.84 | 2M |
| 17 September 2026 | 89.09 | 89.16 | 87.30 | 87.53 | 1M |
| 16 September 2026 | 90.04 | 91.87 | 88.68 | 88.83 | 977,300 |
| 15 September 2026 | 89.54 | 91.86 | 89.38 | 90.06 | 1M |
| 14 September 2026 | 88.28 | 90.32 | 88.05 | 89.82 | 779,300 |
| 11 September 2026 | 88.66 | 88.84 | 86.65 | 87.45 | 774,400 |